Yazar "Cakar, Merih Kizil" için listeleme
-
Brentuximab Vedotin And Bendamustine: An Effective Salvage Therapy For Relapsed Or Refractory Hodgkin Lymphoma Patients
Ulu, Bahar Uncu; Dal, Mehmet Sinan; Hindilerden, Ipek Yonal; Akay, Olga Meltem; Mehtap, Ozgur; Buyukkurt, Nurhilal; Hindilerden, Fehmi; Gunes, Ahmet Kursad; Yigenoglu, Tugce Nur; Basci, Semih; Cakar, Merih Kizil; Acik, Didar Yanardag; Korkmaz, Serdal; Ulas, Turgay; Ozet, Gulsum; Ferhanoglu, Burhan; Nalcaci, Meliha; Altuntas, Fevzi (2022)The prognosis is poor for relapsed or refractory (R/R) classical Hodgkin Lymphoma (cHL) patients. The brentuximab vedotin (Bv) and bendamustine (B) combination has been used as a preferable salvage regimen in R/R cHL patient ... -
Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable >= Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey
Beksac, Meral; Seval, Guldane Cengiz; Paydas, Semra; Tuglular, Tulin Firatli; Arslan, Onder; Goker, Hakan; Kaynar, Leylagul; Altuntas, Fevzi; Atalay, Figen; Teke, Havva Uskudar; Bolaman, Ali Zahit; Pehlivan, Mustafa; Sonmez, Mehmet; Demir, Ahmet Muzaffer; Topcuoglu, Pervin; Yilmaz, Mehmet; Kabukcu, Sibel Hacioglu; Albayrak, Murat; Yurttas, Nurgul Ozer; Salihoglu, Ayse; Cakar, Merih Kizil; Gurman, Gunhan (2019)